T Cell News and Research

Latest T Cell News and Research

Key to treat deadly cancers could lie deep within complex machinery of human cell

Buried deep within the dazzlingly intricate machinery of the human cell could lie a key to treating a range of deadly cancers, according to a team of scientists at Florida State University.

27 Feb 2019

Pioneering clinical trials offers hope to restore damaged cells in Parkinson's disease

The three-part multimillion-pound GDNF study was funded by Parkinson's UK with support from The Cure Parkinson's Trust and in association with the North Bristol NHS Trust.

26 Feb 2019

Cancer genes’ mutational status influenced by their evolutionary age, regulatory functions

Researchers have provided new insight on why some genes that formed during the evolution of the earliest animals on earth are particularly impaired (or dysregulated) by specific mechanisms during cancer development.

26 Feb 2019

Groundbreaking AI technology could predict melanoma metastasis

An interdisciplinary team of researchers at Ben-Gurion University of the Negev in Israel and the University of Texas Southwestern Medical Center in Dallas have developed groundbreaking technology to identify melanoma cells that are likely to metastasize to other parts of the body using artificial intelligence.

26 Feb 2019

Novel mechanism behind DNA damage control uncovered

DNA damage is occurring in our cells all the time due to external agents, such as exposure to sun, or internal agents, like reactive oxygen species.

26 Feb 2019

$Hip fractures may serve as first sign of undiagnosed Alzheimer’s disease$

Hip fractures may serve as first sign of undiagnosed Alzheimer’s disease

In a study of older people with no clinical diagnosis or signs of dementia when hospitalized to repair hip fractures, Johns Hopkins researchers say they found biomarkers of Alzheimer’s disease in most of the patients’ spinal fluid samples.

26 Feb 2019

Tomocube’s holotomography microscopes set to advance long-term studies of live cells

Long-term studies of live cells are set to take a significant leap forward with the introduction of a motorized stage and custom-designed stitching software for Tomocube’s holotomography microscopes.

From Tomocube Inc. 26 Feb 2019

Scientists use CRISPR to reveal the secret life of antimicrobial peptides

When it comes to the immune system, we usually think about lymphocytes like B and T cells or macrophages going on constant seek-and-destroy missions against invading pathogens like bacteria and viruses.

26 Feb 2019

Biophysicists visualize atomic-level dynamics of largest protein-degrading machine

Protein dynamics are essential for their functions. Protein nanomachines made of multiple protein molecules are highly dynamics during their actions on their functional targets, sometime called substrates.

26 Feb 2019

Least-active neurons play more important role in brain behavior than previously assumed

Brain cells recorded as among the least electrically active during a specific task may be the most important to doing it right.

26 Feb 2019

Newly developed probe looks, acts, and feels so much like real neuron

Like a well-guarded fortress, the human brain attacks intruders on sight. Foreign objects, including neural probes used to study and treat the brain, do not last long.

26 Feb 2019

Novel 3D hydrogel helps researchers to quickly screen potential cancer drugs

A 3D hydrogel created by researchers in U of T Engineering Professor Molly Shoichet's lab is helping University of Ottawa researchers to quickly screen hundreds of potential drugs for their ability to fight highly invasive cancers.

26 Feb 2019

Study uncovers potential role of Foxp1 protein in control of autoimmune diseases

Scientists at the Higher School of Economics, the Institute of Bioorganic Chemistry of the Russian Academy of Sciences, and the Memorial Sloan Kettering Cancer Center created a genetic model that helps to understand how the body restrains autoimmune and oncological diseases.

26 Feb 2019

Researchers outline targeted therapeutic strategy for triple-negative breast cancer

New findings put forth by the University of Maryland Fischell Department of Bioengineering and researchers from four other academic institutions outline a targeted therapeutic strategy to treat triple-negative breast cancer - a potential first for the particularly aggressive form of breast cancer.

26 Feb 2019

New protein 'switch' could stop progression of blood-poisoning and increase chances of survival

Scientists at the University of British Columbia have discovered a new protein "switch" that could stop the progression of blood-poisoning, or sepsis, and increase the chances of surviving the life-threatening disease.

26 Feb 2019

'Chromosome scanner' that protects against cancer identified

In a new study, researchers from the University of Copenhagen have identified one of the main mechanisms behind the repair of serious damage to the human DNA. A 'scanner' inside the cells decides whether or not so-called flawless DNA repair, which protects against cancer, is launched.

26 Feb 2019

Scientists report new and improved method to detect chemical modifications to DNA

Ludwig Cancer Research scientists report in the current issue of Nature Biotechnology a new and improved method to detect chemical modifications to DNA.

26 Feb 2019

Immunologists uncover the immune system's unknown messenger

A novel messenger which alarms nearby cells when the immune system recognizes infections has been uncovered by immunologists from Aarhus University, Denmark. This knowledge will help fighting infections and autoimmune diseases.

26 Feb 2019

New microfluidic device can isolate individual cancer cells from blood samples

Researchers at the University of Illinois at Chicago and Queensland University of Technology of Australia, have developed a device that can isolate individual cancer cells from patient blood samples. The microfluidic device works by separating the various cell types found in blood by their size.

26 Feb 2019

Killer T cells may explain inability of immune cells to destroy cancer tumors

Scientists at the University of Virginia School of Medicine have discovered a defect in immune cells known as "killer T cells" that explains their inability to destroy cancer tumors. The researchers believe that repairing this defect could make the cells much better cancer killers.

26 Feb 2019

T Cell News and Research

Latest T Cell News and Research

Key to treat deadly cancers could lie deep within complex machinery of human cell

Pioneering clinical trials offers hope to restore damaged cells in Parkinson's disease

Cancer genes’ mutational status influenced by their evolutionary age, regulatory functions

Groundbreaking AI technology could predict melanoma metastasis

Novel mechanism behind DNA damage control uncovered

Hip fractures may serve as first sign of undiagnosed Alzheimer’s disease

Tomocube’s holotomography microscopes set to advance long-term studies of live cells

Scientists use CRISPR to reveal the secret life of antimicrobial peptides

Biophysicists visualize atomic-level dynamics of largest protein-degrading machine

Least-active neurons play more important role in brain behavior than previously assumed

Newly developed probe looks, acts, and feels so much like real neuron

Novel 3D hydrogel helps researchers to quickly screen potential cancer drugs

Study uncovers potential role of Foxp1 protein in control of autoimmune diseases

Researchers outline targeted therapeutic strategy for triple-negative breast cancer

New protein 'switch' could stop progression of blood-poisoning and increase chances of survival

'Chromosome scanner' that protects against cancer identified

Scientists report new and improved method to detect chemical modifications to DNA

Immunologists uncover the immune system's unknown messenger

New microfluidic device can isolate individual cancer cells from blood samples

Killer T cells may explain inability of immune cells to destroy cancer tumors

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in